Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Oxford BioMedica PLC | 4.130% | 13.514% | 13.514% | -47.500% | 3.279% | -79.174% | -68.101% |
Viracta Therapeutics Inc. | 4.140% | - | - | - | - | - | - |
Bastide Le Confort | 4.200% | 14.493% | 24.677% | -37.706% | -37.143% | -62.381% | - |
Biocept Inc. | 4.240% | - | - | - | - | - | - |
Ekso Bionics Holdings Inc. | 4.240% | -13.655% | -17.939% | -21.303% | -34.690% | -76.620% | - |
Simulations Plus | 4.290% | - | - | - | - | - | - |
Thermogenesis Holdings Inc. | 4.350% | 5.263% | -3.226% | -69.849% | 5.263% | -99.399% | -99.429% |
Voyager Therapeutics Inc | 4.410% | -1.656% | -19.034% | 7.955% | -10.377% | 68.679% | - |
Arbutus Biopharma Corp. | 4.550% | -1.167% | 6.054% | 12.141% | 10.675% | -9.929% | 9.767% |
Shanghai Fosun Pharmaceutical Group Co Ltd | 4.560% | 1.661% | -7.581% | -46.280% | -27.906% | -71.265% | - |
Ocular Therapeutix Inc. | 4.600% | -9.397% | -47.359% | -21.156% | 5.696% | -66.145% | 19.995% |
CareRx Corp. | 4.610% | 9.655% | 23.256% | 8.163% | 59.799% | -61.029% | -57.027% |
Acer Therapeutics Inc | 4.770% | - | - | - | - | - | - |
Geron Corp. | 4.860% | 2.018% | 15.924% | 64.100% | 79.776% | 183.040% | 114.554% |
Biomark Diagnostics Inc. | 4.890% | 5.464% | 3.209% | 50.781% | 17.683% | -45.480% | 311.514% |
Generex Biotechnology | 4.940% | - | - | - | - | - | - |
Haemonetics Corp. | 4.970% | 11.921% | 7.643% | 12.667% | 9.740% | 55.046% | 11.082% |
Neurosearch As Nam. | 4.970% | 2.213% | -1.071% | -23.578% | -6.218% | 8.517% | 219.637% |
INSYS Therapeutics Inc | 5.000% | - | - | - | - | - | - |
Immutep Ltd. | 5.000% | 21.154% | 14.545% | 66.887% | 21.154% | -7.182% | 93.846% |
Eidos Therapeutics | 5.050% | - | - | - | - | - | - |
Actinium Pharmaceuticals Inc. | 5.050% | 0.156% | -12.449% | -19.563% | 42.367% | -3.233% | - |
Evotec SE ADR | 5.130% | -29.624% | -35.448% | -50.737% | -56.262% | - | - |
Quipt Home Medical Corp. | 5.260% | - | - | - | - | - | - |
Vical Inc. | 5.300% | - | - | - | - | - | - |